FDA Leadership Changes After Commissioner Departure

Marty Makary has stepped down as FDA commissioner. An acting replacement is now in charge of the agency. U.S. food supply. Career scientists and inspectors carry out most of the agency's daily work.

Commissioners set priorities and shape how the agency communicates decisions. They also influence how quickly the FDA acts on new treatments or safety concerns. Former FDA deputy commissioner Joshua Sharfstein stated that public trust depends on transparent processes and scientific review.

Vaccine policy, teen vaping, abortion medication, and accelerated drug approvals were among the issues during Makary's time in the role. Different groups raised concerns about the pace and transparency of some decisions. Patients, physicians, companies, and researchers rely on the FDA for consistent standards.

Leadership changes can affect how those standards are applied and how the public views the agency's work.